HHSC: Drug Utilization Review Board
Meeting Summary. The Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs.
The DUR board is composed of 20 total members: 17 physicians and pharmacists who provide services across the entire population of Medicaid recipients and who represent different specialties, two representatives from Medicaid managed care organizations as nonvoting members, and a consumer advocate representing people enrolled in the Medicaid program.
Introduction
The meeting was called to order by the Chair, Robert Hogue, MD. The minutes from the meeting on January 26, 2018, were approved as written.
Members:
Read more